Annual Accounts Receivable
$5.57 M
+$2.30 M+70.13%
December 31, 2023
Summary
- As of February 7, 2025, AQST annual accounts receivable is $5.57 million, with the most recent change of +$2.30 million (+70.13%) on December 31, 2023.
- During the last 3 years, AQST annual accounts receivable has risen by +$1.24 million (+28.64%).
- AQST annual accounts receivable is now -47.73% below its all-time high of $10.66 million, reached on December 31, 2016.
Performance
AQST Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$7.71 M
+$3.38 M+78.13%
September 30, 2024
Summary
- As of February 7, 2025, AQST quarterly accounts receivable is $7.71 million, with the most recent change of +$3.38 million (+78.13%) on September 30, 2024.
- Over the past year, AQST quarterly accounts receivable has increased by +$869.00 thousand (+12.69%).
- AQST quarterly accounts receivable is now -58.56% below its all-time high of $18.62 million, reached on March 31, 2022.
Performance
AQST Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AQST Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.1% | +12.7% |
| 3 y3 years | +28.6% | +12.7% |
| 5 y5 years | -15.0% | +12.7% |
AQST Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.5% | +70.1% | -58.6% | +135.6% |
| 5 y | 5-year | -42.5% | +70.1% | -58.6% | +135.6% |
| alltime | all time | -47.7% | +70.1% | -58.6% | +135.6% |
Aquestive Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.71 M(+78.1%) |
| Jun 2024 | - | $4.33 M(-35.4%) |
| Mar 2024 | - | $6.70 M(+20.3%) |
| Dec 2023 | $5.57 M(+70.1%) | $5.57 M(-18.6%) |
| Sep 2023 | - | $6.85 M(-14.1%) |
| Jun 2023 | - | $7.97 M(+93.3%) |
| Mar 2023 | - | $4.12 M(+25.9%) |
| Dec 2022 | $3.27 M(-66.2%) | $3.27 M(-65.0%) |
| Sep 2022 | - | $9.36 M(-42.4%) |
| Jun 2022 | - | $16.24 M(-12.8%) |
| Mar 2022 | - | $18.62 M(+92.4%) |
| Dec 2021 | $9.68 M | $9.68 M(-15.8%) |
| Sep 2021 | - | $11.50 M(+19.5%) |
| Jun 2021 | - | $9.63 M(+18.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $8.13 M(+87.7%) |
| Dec 2020 | $4.33 M(-52.4%) | $4.33 M(-35.0%) |
| Sep 2020 | - | $6.66 M(-43.6%) |
| Jun 2020 | - | $11.81 M(+39.4%) |
| Mar 2020 | - | $8.47 M(-6.9%) |
| Dec 2019 | $9.09 M(+38.8%) | $9.09 M(-6.1%) |
| Sep 2019 | - | $9.69 M(-3.5%) |
| Jun 2019 | - | $10.04 M(+37.0%) |
| Mar 2019 | - | $7.33 M(+11.8%) |
| Dec 2018 | $6.55 M(+7.4%) | $6.55 M(-11.8%) |
| Sep 2018 | - | $7.43 M(+13.0%) |
| Jun 2018 | - | $6.58 M(-29.2%) |
| Mar 2018 | - | $9.29 M(+52.3%) |
| Dec 2017 | $6.10 M(-42.7%) | $6.10 M |
| Dec 2016 | $10.66 M | - |
FAQ
- What is Aquestive Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Aquestive Therapeutics?
- What is Aquestive Therapeutics annual accounts receivable year-on-year change?
- What is Aquestive Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Aquestive Therapeutics?
- What is Aquestive Therapeutics quarterly accounts receivable year-on-year change?
What is Aquestive Therapeutics annual accounts receivable?
The current annual accounts receivable of AQST is $5.57 M
What is the all time high annual accounts receivable for Aquestive Therapeutics?
Aquestive Therapeutics all-time high annual accounts receivable is $10.66 M
What is Aquestive Therapeutics annual accounts receivable year-on-year change?
Over the past year, AQST annual accounts receivable has changed by +$2.30 M (+70.13%)
What is Aquestive Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of AQST is $7.71 M
What is the all time high quarterly accounts receivable for Aquestive Therapeutics?
Aquestive Therapeutics all-time high quarterly accounts receivable is $18.62 M
What is Aquestive Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, AQST quarterly accounts receivable has changed by +$869.00 K (+12.69%)